diethylnitrosamine has been researched along with End Stage Liver Disease in 1 studies
Diethylnitrosamine: A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties.
N-nitrosodiethylamine : A nitrosamine that is N-ethylethanamine substituted by a nitroso group at the N-atom.
End Stage Liver Disease: Final stage of a liver disease when the liver failure is irreversible and LIVER TRANSPLANTATION is needed.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reebye, V | 1 |
| Huang, KW | 1 |
| Lin, V | 1 |
| Jarvis, S | 1 |
| Cutilas, P | 1 |
| Dorman, S | 1 |
| Ciriello, S | 1 |
| Andrikakou, P | 1 |
| Voutila, J | 1 |
| Saetrom, P | 1 |
| Mintz, PJ | 1 |
| Reccia, I | 1 |
| Rossi, JJ | 1 |
| Huber, H | 1 |
| Habib, R | 1 |
| Kostomitsopoulos, N | 1 |
| Blakey, DC | 1 |
| Habib, NA | 1 |
1 other study available for diethylnitrosamine and End Stage Liver Disease
| Article | Year |
|---|---|
Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer.
Topics: Animals; CCAAT-Enhancer-Binding Proteins; Diethylnitrosamine; End Stage Liver Disease; Gene Expressi | 2018 |